Evonik (0QDS) Financial Statements
Evonik Financial Overview
Evonik's market cap is currently $9.80B. The company's EPS TTM is $0.26; its P/E ratio is 81.36; and it has a dividend yield of 4.77%. Evonik is scheduled to report earnings on November 3, 2026, and the estimated EPS forecast is $0.59. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 14.07B | $ 15.16B | $ 15.27B | $ 18.49B | $ 14.96B |
| Gross Profit | $ 3.24B | $ 3.74B | $ 3.39B | $ 4.23B | $ 4.03B |
| Operating Income | $ 641.00M | $ 1.04B | $ 630.00M | $ 1.43B | $ 1.24B |
| EBITDA | $ 1.84B | $ 1.76B | $ 991.00M | $ 2.07B | $ 2.18B |
| Net Income | $ 265.00M | $ 222.00M | $ -465.00M | $ 540.00M | $ 746.00M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 619.00M | $ 618.00M | $ 1.03B | $ 1.12B | $ 919.00M |
| Total Assets | $ 19.21B | $ 19.75B | $ 21.26B | $ 21.81B | $ 22.28B |
| Total Debt | $ 3.87B | $ 3.78B | $ 4.25B | $ 4.22B | $ 3.64B |
| Net Debt | $ 3.38B | $ 3.32B | $ 3.50B | $ 3.58B | $ 3.19B |
| Total Liabilities | $ 11.04B | $ 10.65B | $ 12.28B | $ 10.75B | $ 12.91B |
| Stockholders' Equity | $ 8.11B | $ 9.02B | $ 8.91B | $ 10.97B | $ 9.29B |
| Cash Flow | |||||
| Free Cash Flow | $ 695.00M | $ 873.00M | $ 801.00M | $ 785.00M | $ 929.00M |
| Operating Cash Flow | $ 1.44B | $ 1.71B | $ 1.59B | $ 1.65B | $ 1.81B |
| Investing Cash Flow | $ -652.00M | $ -663.00M | $ -653.00M | $ -777.00M | $ -1.07B |
| Financing Cash Flow | $ -731.00M | $ -1.33B | $ -823.00M | $ -672.00M | $ -856.00M |
Currency in EUR